Health Care

New research from Glassdoor, a website where employees can anonymously review their companies, shows that employees define what makes a great CEO based on multiple factors.

Pharmaceutical company AstraZeneca plans to sell its molecule antibiotics business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included.

On a seaside field south of Shanghai, workers are constructing a nuclear reactor that is the flagship for Beijing's ambition to compete with the United States, France and Russia as an exporter of atomic power technology.

Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.

Pharmaceutical company AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer in a deal that could be valued at more than $1.5 billion.

Outrage over Mylan Pharmaceuticals’ price hikes on EpiPens has the ‘Erin Brockovich’ of food calling for a congressional investigation.

McDonald's is recalling millions fitness bands that had been given away in Happy Meals because they might cause skin irritation or burns to children.

Stocks are moderately lower in midday trading Monday as the market drifts between small gains and losses.

Valeant Pharmaceuticals replaced Robert Rosiello as chief financial officer as the embattled company attempts to normalize operations amid a host of ongoing investigations and class action lawsuits.

Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.

Pfizer will pay $81.50 a share, a 21% premium to Medivation's closing stock price Friday. Medivation shares traded up 20% to $80.47 in early trading as Pfizer shares fell 5 cents to $34.92.

Pfizer makes it official. The company is acquiring cancer drug company Medivation in a deal worth $14 billion